Leptin in Anorexia Nervosa and the Resulting Amenorrhea

1. What is Leptin?

2. The Core Mechanism: Leptin as a Permissive Signal for Reproduction

"Leptin promotes the production and release of GnRH by hypothalamic neurons, signaling the brain that fat stores are sufficient to support reproductive function. Low levels of leptin — due to starvation, anorexia, or strenuous exercise — are associated with amenorrhea." — Medical Physiology (Boron & Boulpaep)

↓ Body fat (anorexia nervosa)
     ↓
↓ Leptin secretion from adipocytes
     ↓
↓ Leptin signaling at hypothalamus
     ↓
↓ Kisspeptin / KNDy neuron activation
     ↓
↓↓ GnRH pulse frequency & amplitude
     ↓
↓ LH & FSH from anterior pituitary
     ↓
↓ Ovarian estradiol production
     ↓
Amenorrhea (anovulation + no endometrial cycling)

3. Why Amenorrhea Occurs in Anorexia Nervosa

• High CRH and excess endogenous opioids — both independently inhibit GnRH pulses
• Low T3 (sick euthyroid pattern) and ↑ reverse T3
• Hypercortisolism (despite normal ACTH)
• ↑ Ghrelin — orexigenic peptide elevated in both restricting and binge-purge subtypes; contributes to suppression of the reproductive axis
• ↓ IGF-1 and ↓ insulin-like signaling

4. Functional Hypothalamic Amenorrhea (HA)

"Decreased leptin levels are associated with hypothalamic amenorrhea, regardless of whether it is caused by exercise, eating disorders, or is idiopathic." — Berek & Novak's Gynecology

• β-hCG negative → FSH normal/low → Hypothalamic cause

Harrison's Principles of Internal Medicine 22E — Algorithm for evaluation of amenorrhea

5. Additional Effects of Low Leptin in Anorexia

6. Therapeutic Implications: Exogenous Leptin

• ↑ LH, FSH, and estradiol levels
• ↑ IGF-1 and thyroid hormone
• Restored ovulation and increased bone mineral density

Summary

Leptin and Adiponectin in Diabetes Mellitus

I. LEPTIN

Origin & Normal Function

Leptin in Type 2 Diabetes / Obesity

1. Receptor desensitization from chronic hyperleptinemia — continuous stimulation down-regulates receptor sensitivity
2. SOCS3 induction — leptin itself induces suppressor of cytokine signaling-3 (SOCS3), which antagonizes STAT activation, creating a negative feedback loop that becomes constitutively active

"T2DM results from insulin resistance associated with genetic predisposition, obesity, leptin resistance, diet, smoking, and a host of inflammatory mediators causing beta cell loss or dysfunction." — Murray & Nadel's Textbook of Respiratory Medicine

Leptin's Direct Role in Insulin Resistance

• Impair glucose utilization in skeletal muscle
• Promote hepatic glucose output (gluconeogenesis)
• Impair beta cell function ("lipotoxicity")
• Produce a systemic low-grade inflammatory state that worsens insulin signaling

Leptin in Type 1 Diabetes / Lipodystrophy

II. ADIPONECTIN

Origin & Normal Function

• AdipoR1 — predominantly in skeletal muscle
• AdipoR2 — predominantly in liver

1. AMPK (AMP-activated protein kinase) — the cellular "fuel gauge"
2. PPARα (peroxisome proliferator-activated receptor α) — master regulator of fatty acid oxidation

Adiponectin's Metabolic Actions

Adiponectin
    ├── AdipoR1/R2 →  AMPK activation
    │       ├── Skeletal muscle: ↑ glucose uptake, ↑ fatty acid oxidation
    │       └── Liver: ↑ fatty acid oxidation, ↓ gluconeogenesis, ↓ lipogenesis
    └── PPARα activation
            ├── ↑ Fatty acid oxidation genes
            ├── ↑ Lipoprotein lipase, ↑ apoAI/AII (→ ↑ HDL)
            └── ↓ apoCIII → further ↑ LPL activity

Adiponectin in Type 2 Diabetes / Obesity

"The production by adipocytes of adiponectin, an insulin-sensitizing peptide, is reduced in obesity, and this may contribute to hepatic insulin resistance." — Harrison's Principles of Internal Medicine 22E

• NAFLD/MASLD — reduced hepatic fatty acid oxidation → steatosis and fibrosis
• Dyslipidemia — elevated triglycerides, reduced HDL
• Cardiovascular disease — loss of anti-inflammatory and anti-apoptotic tissue-protective effects
• COPD-like phenotype in animal models (adiponectin-knockout mice)

"Adiponectin exhibits anti-inflammatory, antioxidative, and anti-apoptotic activities; these tissue-protective effects are eliminated in experimental T2DM." — Murray & Nadel's Textbook of Respiratory Medicine

III. COMPARATIVE SUMMARY TABLE

IV. THERAPEUTIC RELEVANCE

Thiazolidinediones (TZDs — e.g., Pioglitazone)

Metformin

SGLT-2 Inhibitors (recent evidence)

V. The Vicious Cycle in T2DM

Obesity (↑ visceral fat)
        ↓
↑ Leptin (resistance) + ↓ Adiponectin
        ↓
↓ AMPK activity in liver & muscle
        ↓
↑ Hepatic glucose output + ↓ muscle glucose uptake
        ↓
Hyperglycemia → beta cell exhaustion → T2DM
        ↓
More fat deposition → worse adipokine imbalance (↑ loop)